Acesso livre
Acesso livre

Infectologia

Autoridade de saúde da França faz recomendações contra o uso da vacina da Moderna em menores de 30 anos de idade.

10 Nov, 2021 | 12:50h

French Health Authority Advises Against Moderna COVID-19 Vaccine for Under 30s – Reuters

Ver também: France advises against Moderna for under-30s over rare heart risk – Associated Press

Conteúdo relacionado: Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.

 

Comentário no Twitter

 

Opinião | Imunidade após recuperação de infecção por SARS-CoV-2.

10 Nov, 2021 | 12:48h

Protective immunity after recovery from SARS-CoV-2 infection – The Lancet Infectious Diseases

 

Comentário no Twitter

 

Um proeminente virologista alerta que a nova pílula contra COVID-19 pode gerar perigosas mutações no vírus. Outros não veem com tanto alarde.

10 Nov, 2021 | 12:47h

A prominent virologist warns COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm – Science

Ponto de vista original: Supercharging New Viral Variants: The Dangers Of Molnupiravir (Part 1) – Forbes

Conteúdos relacionados:

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

Revisão prática | Diagnósticos rápidos de COVID-19.

9 Nov, 2021 | 12:27h

COVID-19 rapid diagnostics: practice review – Emergency Medicine Journal

Um estudo provocador sugere que os sintomas físicos que persistem depois da infecção por COVID-19 podem estar associados mais com a crença de ter sido infectado pelo SARS-CoV-2 do que com uma infecção confirmada em laboratório.

9 Nov, 2021 | 12:25h

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic – JAMA Internal Medicine

Entrevista com os autores: Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms – JAMA Internal Medicine

Comentários: Expert reaction to study looking at the association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms – Science Media Centre

Conteúdos relacionados:

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

 

Comentário no Twitter

 

Linfadenopatia regional pós-vacinação contra COVID-19: revisão da literatura e considerações para a abordagem de pacientes em tratamento de câncer de mama.

9 Nov, 2021 | 12:22h

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer

Conteúdos relacionados:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging.

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

Podemos ter certeza de que houve mais de 5 milhões de mortes por Covid no mundo – “Estimar fatalidades ‘em excesso’, um método de análise mais robusto, mostra que a pandemia custou de 10 milhões a 19 milhões de vidas.”

9 Nov, 2021 | 12:21h

We can be confident there have been far more than 5 million global Covid deaths – The Guardian

Conteúdos relacionados:

Global Covid-19 deaths surpass five million.

Effects of the Covid-19 pandemic on life expectancy and premature mortality in 2020 – this time series analysis showed there were more than 28 million excess years of life lost in 2020 in 31 countries.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

Como as vacinas contra COVID baseadas em proteína podem mudar a pandemia.

9 Nov, 2021 | 12:19h

How protein-based COVID vaccines could change the pandemic – Nature

Sprays nasais, adesivos livres de agulhas, imunidade duradoura: a próxima geração de vacinas contra COVID.

9 Nov, 2021 | 12:18h

Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccines – The Conversation

 

Nem todas as ondas de Covid são parecidas. Uma análise do aumento da variante Delta.

9 Nov, 2021 | 12:17h

Not all Covid waves look the same. Here’s a snapshot of the Delta surge – STAT

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.